Bruker Corporation (NASDAQ: BRKR) is 3.61% higher on its value in year-to-date trading and has touched a low of $48.42 and a high of $84.84 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BRKR stock was last observed hovering at around $71.00 in the last trading session, with the day’s loss setting it -0.18% off its average median price target of $89.50 for the next 12 months. It is also 27.73% off the consensus price target high of $98.00 offered by 10 analysts, but current levels are 2.99% higher than the price target low of $73.00 for the same period.
Currently trading at $70.82, the stock is -7.05% and -8.44% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -0.25% at the moment leaves the stock 4.82% off its SMA200. BRKR registered 18.61% gain for a year compared to 6-month gain of 3.67%. The firm has a 50-day simple moving average (SMA 50) of $4.81 and a 200-day simple moving average (SMA200) of $23.00.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The stock witnessed a -8.61% loss in the last 1 month and extending the period to 3 months gives it a 2.05%, and is -4.98% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.14% over the week and 3.13% over the month.
Bruker Corporation (BRKR) has around 8525 employees, a market worth around $10.21B and $2.62B in sales. Current P/E ratio is 33.72 and Fwd P/E is 24.39. Profit margin for the company is 11.90%. Distance from 52-week low is 46.26% and -16.53% from its 52-week high. The company has generated returns on investments over the last 12 months (13.60%).
Bruker Corporation (BRKR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Bruker Corporation (BRKR) is a “Overweight”. 10 analysts offering their recommendations for the stock have an average rating of 2.10, where 4 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Bruker Corporation is expected to release its quarterly report on 08/03/2023.The EPS is expected to grow by 9.50% this year
Bruker Corporation (BRKR) Top Institutional Holders
The shares outstanding are 146.80M, and float is at 98.87M with Short Float at 3.10%.
Bruker Corporation (BRKR) Insider Activity
A total of 21 insider transactions have happened at Bruker Corporation (BRKR) in the last six months, with sales accounting for 8 and purchases happening 13 times. The most recent transaction is an insider sale by Kastner Marc A, the company’s Director. SEC filings show that Kastner Marc A sold 11,146 shares of the company’s common stock on May 19 at a price of $75.22 per share for a total of $0.84 million. Following the sale, the insider now owns 8051.0 shares.
Bruker Corporation disclosed in a document filed with the SEC on May 16 that LAUKIEN FRANK H (PRESIDENT & CEO) sold a total of 14,625 shares of the company’s common stock. The trade occurred on May 16 and was made at $73.11 per share for $1.07 million. Following the transaction, the insider now directly holds 38.18 million shares of the BRKR stock.
Still, SEC filings show that on May 15, LAUKIEN FRANK H (PRESIDENT & CEO) disposed off 185,375 shares at an average price of $72.75 for $13.49 million. The insider now directly holds 38,262,287 shares of Bruker Corporation (BRKR).
Bruker Corporation (BRKR): Who are the competitors?
The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -5.13% down over the past 12 months and Illumina Inc. (ILMN) that is -19.45% lower over the same period. Revvity Inc. (RVTY) is -19.19% down on the 1-year trading charts.